Shuttle Pharmaceuticals Holdings annual depreciation and amortization
2021
2022
2023
2024
2025
Shuttle Pharmaceuticals Holdings Depreciation & Amortization Growth & History (SHPH)
Shuttle Pharmaceuticals Holdings's depreciation and amortization was $290,107 for fiscal 2025.
View full Shuttle Pharmaceuticals Holdings company overviewShuttle Pharmaceuticals Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $290,107 | $284,644 | +5210.40% |
| 2024 | 2024-12-31 | $5,463 | −$1,348 | −19.79% |
| 2023 | 2023-12-31 | $6,811 | $839 | +14.05% |
| 2022 | 2022-12-31 | $5,972 | −$246 | −3.96% |
| 2021 | 2021-12-31 | $6,218 | — | — |
Shuttle Pharmaceuticals Holdings quarterly depreciation and amortization
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $633,340 | $632,332 | +62731.35% |
| Q4 2025 | 2025-12-31 | $289,070 | — | — |
| Q3 2025 | 2025-09-30 | $1,008 | $215 | +27.11% |
| Q2 2025 | 2025-06-30 | −$979 | −$1,941 | — |
| Q1 2025 | 2025-03-31 | $1,008 | −$904 | −47.28% |
| Q3 2024 | 2024-09-30 | $793 | −$1,065 | −57.32% |
| Q2 2024 | 2024-06-30 | $962 | −$520 | −35.09% |
| Q1 2024 | 2024-03-31 | $1,912 | $424 | +28.49% |
| Q3 2023 | 2023-09-30 | $1,858 | $273 | +17.22% |
| Q2 2023 | 2023-06-30 | $1,482 | $33 | +2.28% |
| Q1 2023 | 2023-03-31 | $1,488 | $38 | +2.62% |
| Q3 2022 | 2022-09-30 | $1,585 | — | — |
| Q2 2022 | 2022-06-30 | $1,449 | — | — |
| Q1 2022 | 2022-03-31 | $1,450 | — | — |
Shuttle Pharmaceuticals Holdings depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Shuttle Pharmaceuticals Holdings's depreciation and amortization increased from $6,218 to $290,107, a change of $283,889. The latest reported quarter, Q1 2026, shows $633,340.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Shuttle Pharmaceuticals Holdings source filings ↗